Distally, deficiency of NFE2L3 coincides with a loss of mast cells and a decrease in tumor burden, whereas proximally it promotes Treg infiltration and subsequent reduction of inflammation (Fig. 6b). The gene discussed is NFE2L3; the disease is neoplasm.